Literature DB >> 27057058

Cutaneous Leukocytoclastic Vasculitis Associated with Erlotinib.

Takahiro Sawada1, Mitsuhiro Suehiro2, Osamu Hiranuma3.   

Abstract

Entities:  

Year:  2016        PMID： 27057058      PMCID： PMC4817483          DOI： 10.4103/0019-5154.177793

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN： 0019-5154            Impact factor:   1.494


× No keyword cloud information.
  5 in total

Review 1.  [A case of cutaneous vasculitis caused by erlotinib treatment and a review of literature].

Authors:  Yoko Takahashi; Noriyuki Ebi; Ou Yamaguchi; Risa Fukusho; Yukihiro Sugimoto; Kosuke Tsuruno
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2011-09

2.  Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.

Authors:  S Boeck; A Wollenberg; V Heinemann
Journal:  Ann Oncol       Date:  2007-09       Impact factor: 32.976

3.  Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinib-associated leukocytoclastic vasculitis: A case report.

Authors:  Bo-An Su; Wan-Lin Shen; Sheng-Tsung Chang; Li-Yia Feng; Chia-Jung Wu; Yin-Hsun Feng
Journal:  Oncol Lett       Date:  2012-03-16       Impact factor: 2.967

4.  [Henoch-schönlein purpura induced by erlotinib (Tarceva): a case report].

Authors:  Tatsuya Yuba; Kazuhiro Nagata; Shinsuke Shiotsu; Akira Okano; Mayumi Hatsuse; Satoshi Murakami; Kiyoshi Morihara; Chihiro Shimazaki
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2010-01

5.  Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?

Authors:  Giovanni Brandi; Michela Venturi; Emi Dika; Howard Maibach; Annalisa Patrizi; Guido Biasco
Journal:  Cutan Ocul Toxicol       Date:  2013-03-27       Impact factor: 1.820
  5 in total
  1 in total

1.  Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein.

Authors:  Tamio Okimoto; Yukari Tsubata; Takamasa Hotta; Megumi Hamaguchi; Takae Okuno; Yohei Shiratsuki; Akari Kodama; Mika Nakao; Yoshihiro Amano; Shunichi Hamaguchi; Noriaki Kurimoto; Reiko Tobita; Takeshi Isobe
Journal:  Oncotarget       Date:  2018-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.